loading
前日終値:
$22.80
開ける:
$22.76
24時間の取引高:
119.23K
Relative Volume:
0.20
時価総額:
$984.33M
収益:
$681.75M
当期純損益:
$70.47M
株価収益率:
15.78
EPS:
1.45
ネットキャッシュフロー:
$173.19M
1週間 パフォーマンス:
-3.87%
1か月 パフォーマンス:
+3.81%
6か月 パフォーマンス:
-12.55%
1年 パフォーマンス:
+31.53%
1日の値動き範囲:
Value
$22.29
$22.90
1週間の範囲:
Value
$22.29
$24.95
52週間の値動き範囲:
Value
$16.29
$27.98

Pacira Biosciences Inc Stock (PCRX) Company Profile

Name
名前
Pacira Biosciences Inc
Name
セクター
Healthcare (1137)
Name
電話
650-242-8052
Name
住所
2000 SIERRA POINT PARKWAY, BRISBANE, NJ
Name
職員
790
Name
Twitter
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
PCRX's Discussions on Twitter

PCRX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
PCRX
Pacira Biosciences Inc
22.88 980.89M 681.75M 70.47M 173.19M 1.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
118.05 51.07B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.27 44.42B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.9025 42.75B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
24.14 27.86B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
474.73 20.44B 3.08B 1.24B 1.07B 25.61

Pacira Biosciences Inc Stock (PCRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-17 開始されました H.C. Wainwright Buy
2025-07-25 アップグレード Truist Hold → Buy
2025-01-30 アップグレード Truist Sell → Hold
2024-08-13 ダウングレード Truist Buy → Sell
2024-08-12 ダウングレード JP Morgan Overweight → Underweight
2024-08-12 ダウングレード Piper Sandler Overweight → Neutral
2024-08-12 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2024-08-12 ダウングレード Raymond James Outperform → Mkt Perform
2024-07-03 ダウングレード Barclays Overweight → Equal Weight
2024-03-07 再開されました JP Morgan Overweight
2023-12-20 開始されました Raymond James Outperform
2023-08-03 アップグレード TD Cowen Market Perform → Outperform
2023-01-31 再開されました Wedbush Outperform
2022-10-21 再開されました Jefferies Buy
2022-01-03 再開されました JP Morgan Overweight
2021-07-26 アップグレード JP Morgan Neutral → Overweight
2021-04-21 再開されました JP Morgan Neutral
2021-04-09 開始されました Berenberg Buy
2021-04-07 再開されました RBC Capital Mkts Outperform
2021-02-11 ダウングレード Northland Capital Outperform → Market Perform
2021-01-21 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-09-21 アップグレード Northland Capital Market Perform → Outperform
2020-07-06 繰り返されました Needham Buy
2020-05-27 開始されました Guggenheim Neutral
2020-04-07 開始されました Northland Capital Outperform
2020-03-20 アップグレード SVB Leerink Mkt Perform → Outperform
2020-02-24 繰り返されました H.C. Wainwright Buy
2020-01-24 開始されました SunTrust Buy
2020-01-23 開始されました SunTrust Buy
2019-11-06 開始されました BTIG Research Buy
2019-06-11 開始されました Barclays Overweight
2019-05-06 アップグレード Mizuho Underperform → Neutral
2019-05-02 アップグレード Stifel Sell → Hold
2019-02-01 ダウングレード Mizuho Neutral → Underperform
2018-08-06 ダウングレード BofA/Merrill Buy → Neutral
2018-04-09 繰り返されました H.C. Wainwright Buy
2018-03-21 繰り返されました Mizuho Neutral
2018-02-16 ダウングレード Needham Buy → Hold
2018-01-19 開始されました Seaport Global Securities Buy
2018-01-04 繰り返されました Canaccord Genuity Buy
2018-01-03 開始されました Leerink Partners Mkt Perform
すべてを表示

Pacira Biosciences Inc (PCRX) 最新ニュース

pulisher
03:52 AM

What macro factors could drive Pacira BioSciences Inc. (82P) stock higherJuly 2025 Highlights & Safe Swing Trade Setup Alerts - newser.com

03:52 AM
pulisher
Nov 20, 2025

Pacira BioSciences, Inc. (PCRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Nov 20, 2025
pulisher
Nov 20, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Stockholders to Reach Out - ACCESS Newswire

Nov 20, 2025
pulisher
Nov 20, 2025

Is Pacira BioSciences Inc. (82P) stock attractive for dividend growth2025 Volatility Report & Fast Exit and Entry Trade Guides - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Pacira BioSciences Inc. (82P) stock a top pick for value investorsMarket Sentiment Report & Weekly Sector Rotation Insights - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Pacira BioSciences Inc. stock rally after Fed decisionsJuly 2025 Retail & AI Forecasted Entry and Exit Points - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How Pacira BioSciences Inc. (82P) stock moves in volatile trading sessions2025 Short Interest & Fast Gaining Stock Reports - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Pacira BioSciences Inc. (82P) stock beat Nasdaq index returnsWeekly Trend Report & Daily Chart Pattern Signals - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

How Pacira BioSciences Inc. stock valuations compare to rivalsTrade Exit Report & Advanced Swing Trade Entry Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What is the fair value estimate for Pacira BioSciences Inc. (82P) stock in 2025Weekly Trade Analysis & Technical Buy Zone Confirmations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Pacira BioSciences Inc. (82P) stock attracts wealthy investorsEarnings Growth Summary & Fast Gain Stock Trading Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRX) Investors to Inquire about Securities Investigation - ACCESS Newswire

Nov 19, 2025
pulisher
Nov 19, 2025

Insider Sell: Jonathan Slonin Sells Shares of Pacira BioSciences Inc (PCRX) - GuruFocus

Nov 19, 2025
pulisher
Nov 19, 2025

Real time social sentiment graph for Pacira BioSciences Inc.Weekly Trade Summary & Community Consensus Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Pacira BioSciences Inc. (82P) stock deliver compounding returnsBull Run & Weekly Top Gainers Trade List - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Should I hold or sell Pacira BioSciences Inc. stock in 20252025 Performance Recap & Real-Time Buy Signal Notifications - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Pacira BioSciences Inc. (82P) stock valuation compares with sector2025 Volume Leaders & AI Forecasted Entry and Exit Points - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Pacira BioSciences Inc. stock poised for growthTrade Volume Summary & Entry Point Confirmation Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Pacira BioSciences Inc. stock keep outperforming rivalsWeekly Market Summary & Real-Time Buy Signal Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Pacira BioSciences Inc. (82P) stock benefit from mergers2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Using data tools to time your Pacira BioSciences Inc. exitJuly 2025 Chart Watch & Daily Market Momentum Tracking - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

(PCRX) Risk Channels and Responsive Allocation - news.stocktradersdaily.com

Nov 19, 2025
pulisher
Nov 18, 2025

How to use a screener to detect Pacira BioSciences Inc. breakoutsFed Meeting & Safe Capital Investment Plans - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

What analysts say about Pacira BioSciences Inc 82P stockPrice-to-Book Ratio Updates & Free Real-Time Trading Signals - earlytimes.in

Nov 18, 2025

Pacira Biosciences Inc (PCRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$33.53
price up icon 0.00%
$21.85
price up icon 2.88%
drug_manufacturers_specialty_generic RDY
$13.93
price up icon 0.18%
$10.21
price up icon 0.25%
$142.06
price up icon 2.28%
$474.60
price down icon 0.01%
大文字化:     |  ボリューム (24 時間):